KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Accured Expenses (2016 - 2026)

Medtronic's Change in Accured Expenses history spans 13 years, with the latest figure at $703.0 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 27.82% to $703.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $289.0 million, a 40.66% decrease, with the full-year FY2025 number at $209.0 million, down 46.55% from a year prior.
  • Change in Accured Expenses hit $703.0 million in Q1 2026 for Medtronic, up from -$182.0 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for MDT hit a ceiling of $703.0 million in Q1 2026 and a floor of -$673.0 million in Q3 2023.
  • Historically, Change in Accured Expenses has averaged $110.5 million across 5 years, with a median of $177.0 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: soared 10250.0% in 2022 and later plummeted 357.82% in 2023.
  • Tracing MDT's Change in Accured Expenses over 5 years: stood at $133.0 million in 2022, then tumbled by 119.55% to -$26.0 million in 2023, then tumbled by 296.15% to -$103.0 million in 2024, then plummeted by 76.7% to -$182.0 million in 2025, then surged by 486.26% to $703.0 million in 2026.
  • Business Quant data shows Change in Accured Expenses for MDT at $703.0 million in Q1 2026, -$182.0 million in Q4 2025, and -$598.0 million in Q3 2025.